Bone mineral density, biochemical and hormonal profiles in suboptimally treated children and adolescents with β-thalassaemia disease

Clinical Endocrinology

Volumn 58, Issue 3, 2003, Pages 273-279

  Mahachoklertwattana, Pat ^a   Chuansumrit, Ampaiwan ^a   Sirisriro, Rojana ^a   Choubtum, Lulin ^a   Sriphrapradang, Arporn ^a   Rajatanavin, Rajata ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; OSTEOCALCIN; PARATHYROID HORMONE; SOMATOMEDIN BINDING PROTEIN 1; THYROTROPIN;

ABSORPTIOMETRY; ADOLESCENT; ARTICLE; BETA THALASSEMIA; BIOCHEMISTRY; BLOOD LEVEL; BONE AGE; BONE DENSITY; BONE MARROW; BONE MATURATION; BONE MINERAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEMUR NECK; HUMAN; LUMBAR SPINE; MALE; PRIORITY JOURNAL; RADIUS; SCHOOL CHILD; TRANSFUSION; X RAY ANALYSIS;

25-HYDROXYVITAMIN D 2; ADOLESCENT; AGE DETERMINATION BY SKELETON; BETA-THALASSEMIA; BLOOD TRANSFUSION; BODY HEIGHT; BODY WEIGHT; BONE DENSITY; CHILD; CHILD, PRESCHOOL; ERYTHROPOIESIS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; PUBERTY, DELAYED; STATISTICS, NONPARAMETRIC;

EID: 0037335049     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01707.x     Document Type: Article

References (30)

1. Aloia, J.F., Ostuni, J.A., Yeh, J.K. & Zaino, E.C. (1982) Combined vitamin D parathyroid defect in thalassemia major. Archives of Internal Medicine, 142, 831-832.
2. Anapliotou, M.L.G., Kastanias, I.T., Psara, P., Evangelou, E.A., Liparaki, M. & Dimitriou, P. (1995) The contribution of hypogonadism to the development of osteoporosis in thalassemia major: new therapeutic approaches. Clinical Endocrinology, 42, 279-287.
3. Bonjour, P.J., Theintz, G., Buchs, B., Slosman, D. & Rizzoli, R. (1991) Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. Journal of Clinical Endocrinology and Metabolism, 73, 555-563.
4. Bordat, C., Constans, A., Bouet, O., Blanc, I., Trubert, C.L., Girot, R. & Cournot, G. (1993) Iron distribution in thalassemic bone by energy-loss spectroscopy and electron spectroscopic imaging. Calcified Tissue International, 53, 29-37.
5. Brill, P.W., Winchester, P., Giardina, P.J. & Cunningham-Rundles, S. (1991) Deferoxamine-induced bone dysplasia in patients with thalassemia major. American Journal of Radiology, 156, 561-565.
6. Dandoma, P., Menon, R.K., Houlder, S., Thomas, M. & Flynn, D.M. (1987) Serum 1,25 dihydroxyvitamin D and osteocalcin concentrations in thalassemia major. Archives of Disease in Childhood, 62, 474-477.
7. De Virgilis, S., Congia, M., Frau, F., Argiolu, F., Diana, G., Cucca, F., Varsi, A., Sanna, G., Fodde, M., Pirastu, G.F. & Cao, A. (1988) Deferoxamine-induced growth retardation in patients with thalassemia major. Journal of Pediatrics, 113, 661-669.
8. Ebeling, P.R., Jones, J.D.O., Fallon, W.M., Janes, C.H. & Riggs, B.L. (1993) Short term effects of recombinant human insulin-like growth factor-1 on bone turnover in normal women. Journal of Clinical Endocrinology and Metabolism, 77, 1384-1387.
9. Filosa, A., DiMaio, S., Vocca, S., Saviano, A., Esposito, G. & Pagano, L. (1997) Longitudinal monitoring of bone mineral density in thalassemic patients: genetic structure and osteoporosis. Acta Paediatrica, 86, 342-346.
10. Finkelstein, J.S., Neer, R.M., Biller, B.M.K., Crawford, J.D. & Klibanski, A. (1992) Osteopenia in men with a history of delayed puberty. New England Journal of Medicine, 326, 600-604.
11. Gratwick, G.M., Bullough, P.G., Bohne, W.H., Markenson, A.L. & Peterson, C.M. (1978) Thalassemic osteoarthropathy. Annals of Internal Medicine, 88, 494-501.
12. Gruelich, W.W. & Pyle, S.I. (1959) Radiographic Atlas of Skeletal Development of the Hand and Wrist, 2nd edn. Stanford University Press, California.
13. Jensen, C.E., Tuck, S.M., Agnew, J.E., Koneru, S., Morris, R.W., Yardumian, A., Prescott, E., Hoffbrand, A.V. & Wonke, B. (1998) High prevalence of low bone mass in thalassemia major. British Journal of Haematology, 103, 911-915.
14. Johanson, N.A. (1990) Musculoskeletal problems in hemoglobinopathy. Orthopaedic Clinics of North America, 21, 191-198.
15. Johansson, A.G., Forslund, A., Hambraeus, L., Blum, W.F. & Ljunghall, S. (1994) Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men. Journal of Bone Mineral Research, 9, 915-921.
16. Langlois, J.A., Rosen, C.J., Visser, M., Hannan, M.T., Harris, T., Wilson, P.W.F. & Kiel, D.P. (1998) Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham heart study. Journal of Clinical Endocrinology and Metabolism, 83, 4257-4262.
17. Low, L.C.K., Postel-Vinay, M.C., Kwan, E.Y.M. & Cheung, P.T. (1998) Serum growth hormone (GH) binding protein, IGF-1 and IGFBP-3 in patients with β-thalassemia major and the effect of GH treatment. Clinical Endocrinology, 48, 641-646.
18. Lu, P.W., Cowell, C.T., Lloyd-Jones, S.A., Briody, J.N. & Howman-Giles, R. (1996) Volumetric bone mineral density in normal subjects, aged 5-27 years. Journal of Clinical Endocrinology and Metabolism, 81, 1586-1590.
19. Mohamed, N. & Jackson, N. (1998) Severe thalassemia intermedia: clinical problems in the absence of hypertransfusion. Blood Review, 12, 163-170.
20. Moulas, A., Challa, A., Choliasos, N. & Lapatsanis, P.D. (1997) Vitamin D metabolites (25-hydroxyvitamin D, 24,25-dihydroxyvitamin D and 1,25-dihydroxyvitiamin D) and osteocalcin in β-thalassemia. Acta Paediatrica, 86, 594-599.
21. Olivieri, N., Koren, G., Harris, J., Khattak, S., Freedman, M.H., Templeton, D., Bailey, J.D. & Reilly, B.J. (1992) Growth failure and bony changes induced by deferoxamine. American Journal of Pediatric Hematology and Oncology, 14, 48-56.
22. Pollak, R.D., Rachmilewitz, E., Blumenfeld, A., Idelson, M. & Goldfarb, A.W. (2000) Bone mineral metabolism in adults with β-thalassemia major and intermedia. British Journal of Haematology, 111, 902-907.
23. Pootrakul, P., Hungsprenges, S., Fucharoen, S., Baylink, D., Thompson, E., English, E., Lee, M., Burnell, J. & Finch, C. (1981) Relation between erythropoiesis and bone metabolism in thalassemia. New England Journal of Medicine, 304, 1470-1473.
24. Rubin, K., Schirduan, V., Gendreu, P., Sarfarazi, M., Mendola, R. & Dalsky, G. (1993) Predictors of axial and peripheral bone mineral density in healthy children and adolescents, with special attention to the role of puberty. Journal of Pediatrics, 123, 863-870.
25. Schettini, F., Mele, M., Mattia, D.D., Falcone, G. & Addabbo, A.D. (1987) Bone metabolism in thalassemia major. Journal of Pediatrics, 111, 158-159.
26. Seeman, E. (1998) Growth in bone mass and size - are racial and gender differences in bone mineral density more apparent than real? Journal of Clinical Endocrinology and Metabolism, 83, 1414-1419.
27. Soliman, A.T., Banna, N.E., Fattah, M.A.E.I., Zalabani, M.M. & Ansari, B.M. (1998) Bone mineral density in prepubertal children with β-thalassemia: correlation with growth and hormonal data. Metabolism, 47, 541-548.
28. Suthutvoravut, U., Charoenkiatkul, S., Mahachoklertwattana, P., Kosulwat, V., Sirisriro, R., Intaramarn, C., Rojroongwasinkul, N. & Rajatanavin, R. (2001) Bone mass development and determinants in Thai children and adolescents aged 9-18 years. Annals of Nutrition and Metabolism, 45 (Suppl. 1), 256.
29. Wonke, B. (1998) Bone disease in β-thalassemia major. British Journal of Haematology, 103, 897-901.
30. Yanovski, J.A., Sovik, K.N., Nguyen, T.T. & Sebring, N.G. (2000) Insulin-like growth factors and bone mineral density in African American and white girls. Journal of Pediatrics, 137, 826-832.